Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.10 (0.90%)
Bid:
10.75
Ask:
11.55
Spread: 0.80 (7.442%)
Market Cap: £29.91m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

PORTFOLIO UPDATE

26 May 2017 07:26

RNS Number : 3271G
VPC Specialty Lending Invest. PLC
26 May 2017
 

26 May 2017

 

VPC Specialty Lending Investments PLC

(the "Company")

PORTFOLIO UPDATE

In line with the previously stated strategy of reallocating capital from market place lending to balance sheet lending, the Company is pleased to announce that it has sold the majority of its Funding Circle US and Upstart marketplace loans. The loans sold represented 3.65% and 1.48%, respectively, of the Company's NAV as at 31 March 2017. The impact of the two portfolio sales on the Company's NAV, which the Company estimates to be approximately -0.17%, will be reflected in the April NAV announcement. The Company will retain the non-performing Funding Circle US and Upstart loans, which represented 0.68% and 0.21% respectively of the Company's NAV as at 31 March 2017, and the Company has already been provisioned against these loans in line with the Company's reserving policy. The Company retired the leverage associated with the Upstart loans as part of the transaction, thereby reducing the Company gearing to 0.49x from 0.53x, on a pro forma basis at 31 March 2017.

These tactical sales help accelerate the Company's strategy of reallocating capital away from market place lending investments into balance sheet investments, which consistently have generated higher returns with less volatility. Taking into account the loan sales, the Company's balance sheet investments accounted for 63% of the NAV as at 31 March 2017, as compared to 17% for the marketplace loans. The Company expects to re-invest substantially all of the sale proceeds into balance sheet investments, as well as other strategic uses. The Company will continue to seek tactical opportunities to further reduce its exposure to market place loans where it is accretive to shareholder value.

The information contained in this announcement is inside information. 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Victory Park Capital

Brendan Carroll (Senior Partner and Co-Founder)

Gordon Watson (Partner, Investment Manager)

Cormac Leech (Principal)

 

via MHP (below)

Jefferies International Limited

Tel: +44 20 7029 8000

Gary Gould

Andrew MorrisAndrew Davison

Stifel Nicolas Europe Limited

Tel: +44 20 7710 7600

Neil Winward

Mark Bloomfield

Gaudi Le Roux

MHP (PR Adviser)

Tel: +44 20 3128 8100

Mark Lunn

Tim Rowntree

Kelsey Traynor

Email: vpc@mhpc.com

 

ABOUT VPC Specialty Lending Investments PLC:

VPC Specialty Lending Investments PLC invests in opportunities within the specialty lending market primarily through online lending platforms. The Company intends to generate an attractive total return for shareholders consisting of distributable income and capital growth via investments in a diverse portfolio of various platforms, asset classes, geographies (primarily U.S., U.K., Australia and Europe) and credit bands.

 

Since 2010, the Company's investment manager, VPC, has been actively involved in the specialty lending marketplace and has made more than $5.2 billion of investments and commitments across a number of financial technology platforms, multiple geographies (U.S., U.K., Australia and Europe), products (consumer and business) and structures (whole loans and senior credit facilities).

 

Further information on VPC Specialty Lending Investments PLC is available at: http://vpcspecialitylending.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUEAKSKAAAXEEF
Date   Source Headline
21st May 20205:44 pmRNSTransaction in Own Shares
21st May 20207:01 amRNSNotice of Annual General Meeting
21st May 20207:00 amRNSAnnual Financial Report
12th May 20205:32 pmRNSDirector/PDMR Shareholding
7th May 20207:10 amRNSDividend Declaration
7th May 20207:05 amRNSQuarterly Letter
7th May 20207:00 amRNSNet Asset Value(s)
27th Apr 202010:49 amRNSArticles of Association
23rd Apr 20202:51 pmRNSRevised Publication Date for Annual Report
17th Apr 20204:41 pmRNSSecond Price Monitoring Extn
17th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:35 pmRNSPrice Monitoring Extension
1st Apr 202011:11 amRNSTotal Voting Rights
31st Mar 202010:00 amRNSDirector/PDMR Shareholding
26th Mar 20207:00 amRNSNet Asset Value(s)
23rd Mar 20202:30 pmRNSStatement from Victory Park Capital
19th Mar 20205:32 pmRNSTransaction in Own Shares
18th Mar 20205:45 pmRNSTransaction in Own Shares
17th Mar 20205:21 pmRNSTransaction in Own Shares
16th Mar 20205:37 pmRNSTransaction in Own Shares
13th Mar 20205:22 pmRNSTransaction in Own Shares
12th Mar 20205:25 pmRNSTransaction in Own Shares
11th Mar 20205:20 pmRNSTransaction in Own Shares
11th Mar 20202:00 pmRNSAnnual Letter & Statement on COVID-19
11th Mar 202011:23 amRNSHolding(s) in Company
10th Mar 20205:10 pmRNSTransaction in Own Shares
10th Mar 20203:12 pmRNSDirector/PDMR Shareholding
9th Mar 20205:03 pmRNSTransaction in Own Shares
6th Mar 20205:29 pmRNSTransaction in Own Shares
6th Mar 20207:00 amRNSNet Asset Value(s)
5th Mar 20204:59 pmRNSTransaction in Own Shares
4th Mar 20205:13 pmRNSTransaction in Own Shares
3rd Mar 20205:09 pmRNSTransaction in Own Shares
2nd Mar 20205:30 pmRNSTransaction in Own Shares
2nd Mar 202010:35 amRNSTotal Voting Rights
28th Feb 20205:06 pmRNSTransaction in Own Shares
28th Feb 20209:53 amRNSTransaction in Own Shares
27th Feb 20207:00 amRNSDividend Declaration
25th Feb 202012:00 pmRNSDirector/PDMR Shareholding
25th Feb 202011:59 amRNSDirector/PDMR Shareholding
25th Feb 202011:58 amRNSDirector/PDMR Shareholding
25th Feb 202011:57 amRNSDirector/PDMR Shareholding
25th Feb 202011:15 amRNSHolding(s) in Company
25th Feb 202011:00 amRNSHolding(s) in Company
24th Feb 20204:15 pmRNSInvestor Presentation
24th Feb 20207:00 amRNSAcquisition of Significant Minority Stake
20th Feb 20205:19 pmRNSTransaction in Own Shares
19th Feb 20205:20 pmRNSTransaction in Own Shares
18th Feb 20205:03 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.